CTRI/2011/09/002015已完成3 期
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Fibromyalgia (Protocol A0081245) - Not applicable
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 290
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients must have fibromyalgia.
排除标准
- •Patients with other painful conditions cannot participate.
研究者
相似试验
进行中（未招募）
1 期
Study to evaluate vibegron in men taking stable BPH medications who have overactive bladder symptomsOveractive Bladder (OAB) in men with Benign Prostatic Hyperplasia (BPH)MedDRA version: 23.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857EUCTR2018-003135-30-PTrovant Sciences GmbH1,088
进行中（未招募）
不适用
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study ofthe Safety and Efficacy of Adefovir Dipivoxil in Children andAdolescents (Age 2 to <18) with Chronic Hepatitis BEUCTR2004-001346-33-Outside-EU/EEAGilead Sciences Inc.173
招募中
3 期
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic NeuralgiaCTRI/2011/07/001905Pfizer Limited800
进行中（未招募）
1 期
Study to evaluate vibegron in men taking stable BPH medications who have overactive bladder symptomsOveractive Bladder (OAB) in men with Benign Prostatic Hyperplasia (BPH)MedDRA version: 21.1 Level: LLT Classification code 10059617 Term: Overactive bladder System Organ Class: 100000004857EUCTR2018-003135-30-ESrovant Sciences GmbH1,088
已完成
不适用
Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes Mellitus-E119 Non-insulin-dependent diabetes mellitus, without complications-I10 Essential (primary) hypertensionNon-insulin-dependent diabetes mellitus, without complicationsEssential (primary) hypertensionE119I10PER-096-06TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER, INC.,